List of Articles

Kawasaki Disease. Vol. 3, No. 2, 2025

Review
Scoping Review of Kawasaki Disease Research Using National Databases in Korea
Kawasaki Dis 2025;3(2):e10
https://doi.org/10.59492/kd.2025.3.2.e10
HTML PDF PubReader TDM
Treatment of Acute Stage of Kawasaki Disease Based on Updated 2024 Guidelines from the American Heart Association
2024 AHA 개정 지침 근거 가와사끼병의 급성기 치료
Kawasaki Dis 2025;3(2):e11
https://doi.org/10.59492/kd.2025.3.2.e11
HTML PDF PubReader TDM
Thrombosis in Kawasaki Disease: Implications for Coronary Artery Aneurysm Risk, Diagnosis, and Anti-Thrombotic Management
Kawasaki Dis 2025;3(2):e12
https://doi.org/10.59492/kd.2025.3.2.e12
HTML PDF PubReader TDM
Catheter-Based Revascularization and Antithrombotic Strategies for Post-Kawasaki Disease Coronary Artery Lesions: A Narrative Review of Guideline-Aligned Management
가와사키병에서 관상동맥 병변의 중재술 및 항혈전 전략: 지침 기반 관리
Kawasaki Dis 2025;3(2):e13
https://doi.org/10.59492/kd.2025.3.2.e13
HTML PDF PubReader TDM
Coronary Intervention in Kawasaki Disease
Kawasaki Dis 2025;3(2):e14
https://doi.org/10.59492/kd.2025.3.2.e14
HTML PDF PubReader TDM
Vaccination in Children with Kawasaki Disease Treated with Biological Drugs
생물학적 제제 치료를 받은 가와사키병 소아의 예방접종
Kawasaki Dis 2025;3(2):e15
https://doi.org/10.59492/kd.2025.3.2.e15
HTML PDF PubReader TDM
Original Article
Nationwide Validation of Japanese Initial Intravenous Immunoglobulin (IVIG) Resistance Scores in Korean Children with Kawasaki Disease
Kawasaki Dis 2025;3(2):e16
https://doi.org/10.59492/kd.2025.3.2.e16
HTML PDF PubReader TDM
Toward Integrated Use of BNP and N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP) in Predicting Resistance to Initial Intravenous Immunoglobulin (IVIG) in Acute Phase of Kawasaki Disease
Kawasaki Dis 2025;3(2):e17
https://doi.org/10.59492/kd.2025.3.2.e17
HTML PDF PubReader TDM
Comparison of Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease
소아다기관염증증후군과 가와사키병의 비교
Kawasaki Dis 2025;3(2):e18
https://doi.org/10.59492/kd.2025.3.2.e18
HTML PDF PubReader TDM
Case Report
Pathophysiological Connection between MIS-C Following SARS-CoV-2 Infection and Kawasaki Disease: The Role of ACE2 Expression
Kawasaki Dis 2025;3(2):e19
https://doi.org/10.59492/kd.2025.3.2.e19
HTML PDF PubReader TDM
Atypical Manifestation of Kawasaki Disease Presenting as Acalculous Cholecystitis
Kawasaki Dis 2025;3(2):e20
https://doi.org/10.59492/kd.2025.3.2.e20
HTML PDF PubReader TDM